-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 M4rUPIqgWNAznzeF5nDtjSiF52BvT1wckNjqUNfqEN1rOWJumuICEn+gRDC9eunT
 2+000rGPNJE0OV2E0pbQUg==

<SEC-DOCUMENT>0001144204-10-043213.txt : 20100812
<SEC-HEADER>0001144204-10-043213.hdr.sgml : 20100812
<ACCEPTANCE-DATETIME>20100812162900
ACCESSION NUMBER:		0001144204-10-043213
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20100812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100812
DATE AS OF CHANGE:		20100812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRANSGENOMIC INC
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30975
		FILM NUMBER:		101011493

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		4027385480

	MAIL ADDRESS:	
		STREET 1:		12325 EMMET STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v193592_8k.htm
<TEXT>
<html>
  <head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizer 4.0.6.4-->
    <!--Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved-->
    </head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED
STATES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES
AND EXCHANGE COMMISSION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
D.C.&#160;&#160;20549</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FORM
8-K</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CURRENT
REPORT</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to Section&#160;13 OR 15(d) of The Securities Exchange Act of 1934</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date of
Report (Date of earliest event reported):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">August
12, 2010</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">TRANSGENOMIC,
INC.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact
name of registrant as specified in its charter)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <div>&#160;</div>
      <div>
        <div align="left">
          <div align="left">
            <div align="left">
              <div align="left">
                <div align="left">
                  <div align="left">
                    <div align="left">
                      <div align="left">
                        <div align="left">
                          <div align="left">
                            <table cellpadding="0" cellspacing="0" width="100%">
                                <tr>
                                  <td align="left" valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font size="2">Delaware</font></div>
                                  </td>
                                  <td align="left" valign="top" width="12%" style="PADDING-BOTTOM: 2px">
                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
                                  </td>
                                  <td align="left" valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
                                    <div style="TEXT-ALIGN: center"><font size="2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">000-30975</font></div>
                                  </td>
                                  <td align="left" valign="top" width="12%" style="PADDING-BOTTOM: 2px"><font size="2" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></td>
                                  <td align="left" valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
                                    <div style="TEXT-ALIGN: center"><font size="2">911789357</font></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td align="left" valign="top" width="25%">
                                    <div style="TEXT-ALIGN: center"><font size="2">(State of
      Incorporation)&#160;</font></div>
                                  </td>
                                  <td align="left" valign="top" width="12%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="25%">
                                    <div style="TEXT-ALIGN: center"><font size="2">(Commission File
      Number)&#160;</font></div>
                                  </td>
                                  <td align="left" valign="top" width="12%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="25%">
                                    <div style="TEXT-ALIGN: center"><font size="2">(IRS Employer
      Identification&#160;</font></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td align="left" valign="top" width="25%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="12%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="25%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="12%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="25%">
                                    <div style="TEXT-ALIGN: center"><font size="2">Number)</font></div>
                                  </td>
                                </tr>
                            </table>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
          <div align="left">
            <div align="left">
              <div align="left">
                <div align="left">
                  <div align="left">
                    <div align="left">
                      <div align="left">
                        <div align="left">
                          <div align="center">
                            <table cellpadding="0" cellspacing="0" width="75%">
                                <tr>
                                  <td align="left" valign="top" width="45%" style="BORDER-BOTTOM: black 2px solid">
                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font size="2">12325 Emmet Street, Omaha,
Nebraska</font></div>
                                  </td>
                                  <td align="left" valign="top" width="25%" style="PADDING-BOTTOM: 2px">
                                    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
                                  </td>
                                  <td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font size="2">68164&#160;</font></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td align="left" valign="top" width="45%">
                                    <div style="TEXT-ALIGN: center"><font size="2">(Address of principal
      executive offices)</font></div>
                                  </td>
                                  <td align="left" valign="top" width="25%"><font size="2">&#160;</font></td>
                                  <td align="left" valign="top" width="30%">
                                    <div style="TEXT-ALIGN: center"><font size="2">(Zip
  Code)</font></div>
                                  </td>
                                </tr>
                            </table>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt">
        <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
          <div align="left">
            <div align="left">
              <div align="left">
                <div align="left">
                  <div align="left">
                    <div align="left">
                      <table cellpadding="0" cellspacing="0" width="100%">
                          <tr>
                            <td align="left" valign="top" width="28%" style="PADDING-BOTTOM: 2px"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid">
                              <div style="TEXT-ALIGN: center"><font size="2">(402)
452-5400</font></div>
                            </td>
                            <td align="left" valign="top" width="28%" style="PADDING-BOTTOM: 2px">
                              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font size="2">&#160; </font></div>
                            </td>
                          </tr>
                          <tr>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%">
                              <div style="TEXT-ALIGN: center"><font size="2">(Registrant&#8217;s telephone
      number, including area code)</font></div>
                            </td>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                          </tr>
                          <tr>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                          </tr>
                          <tr>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                          </tr>
                          <tr>
                            <td align="left" valign="top" width="28%" style="PADDING-BOTTOM: 2px"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 2px solid">
                              <div style="TEXT-ALIGN: center"><font size="2">Not
applicable</font></div>
                            </td>
                            <td align="left" valign="top" width="28%" style="PADDING-BOTTOM: 2px"><font size="2">&#160;</font></td>
                          </tr>
                          <tr>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                            <td align="left" valign="top" width="44%">
                              <div style="TEXT-ALIGN: center"><font size="2">(Former name or former
      address, if changed since last report)</font></div>
                            </td>
                            <td align="left" valign="top" width="28%"><font size="2">&#160;</font></td>
                          </tr>
                      </table>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
    <div>
      <div align="center">
        <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top">
              <td style="WIDTH: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;</font></td>
              <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)&#160;</font></td>
            </tr>
            <tr valign="top">
              <td style="WIDTH: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;</font></td>
              <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)&#160;</font></td>
            </tr>
            <tr valign="top">
              <td style="WIDTH: 36pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
              </td>
              <td>
                <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act
      (17&#160;CFR 240.14d-2(b))</font></div>
              </td>
            </tr>
        </table>
      </div>
    </div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top">
            <td style="WIDTH: 48px">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
            </td>
            <td width="792">
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act
      (17&#160;CFR 240.13e-4(c))</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item
2.02 Results of Operations and Financial Condition</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On August
12, 2010, Transgenomic, Inc. issued a press release announcing its financial
results for the second quarter 2010.&#160;&#160;A copy of the press release is
being furnished herewith as Exhibit 99.1 to this Current Report on Form
8-K.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
information referenced in this Current Report on Form 8-K (including Exhibit 99
referenced in Item&#160;9.01 below) is being &#8216;furnished&#8221; under &#8220;Item 2.02.
Results of Operations and Financial Condition&#8221; and, as such, shall not be deemed
to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of
1934, (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that
Section.&#160;&#160;The information set forth in this Current Report on Form 8-K
(including Exhibit 99 referenced in Item 9.01 below) shall not be incorporated
by reference into any registration statement or other document pursuant to the
Securities Act of 1933, (the&#160;&#8220;Securities Act&#8221;), except as shall be
expressly set forth by specific reference in such filing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item
9.01.&#160;&#160;Financial Statements and Exhibits.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top">
            <td align="right" style="WIDTH: 36pt">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;</font></div>
            </td>
            <td align="left">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibits.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top">
            <td style="WIDTH: 36pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(99)</font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Press
      release dated August 12, 2010, announcing Transgenomic, Inc.&#8217;s financial
      results for the second quarter
2010.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <div>
        <div align="left">
          <table border="0" cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td valign="top" width="50%">

                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dated:&#160;&#160;August
      12, 2010</font>&#160;</div>
                </td>
                <td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">TRANSGENOMIC,
      INC.</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      &#160;</font></div>
                </td>
                <td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:
      </font></div>
                </td>
                <td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Brett
      L. Frevert</font></td>
                <td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Brett
      L. Frevert</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interim
      Chief Financial Officer</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
          </table>
        </div>
        <div align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v193592_ex99-1.htm
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;"><div style="width:100%;margin-left:10pt">
<p style="text-align:center"><b>Transgenomic Reports Second Quarter Financial Results</b></p>
<br /><br /><p style="text-align:center">Conference call begins at 5:00 p.m. Eastern Time today</p></div><div style="width:100%;margin-left:10pt;"><div style="margin:0;margin-top:16pt;"><p>OMAHA, Neb., Aug. 12 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today reported financial results for the three and six months ended June 30, 2010, and provided a business update.</p><p><u><b>Six Month Financial Results</b></u></p><p>Net sales were $10.5 million for the six month periods ended June 30, 2010 and 2009. &#160;Gross profit was $5.4 million or 51% of net sales for the 2010 period, compared with gross profit of $5.5 million or 52% of net sales for the 2009 period. &#160;Operating expenses for the first half of 2010 were $6.8 million, which included expense from foreign currency revaluation of $0.5 million. &#160;Operating expenses for the first half of 2009 were $7.2 million, which included expense from foreign currency revaluation of $0.4 million.</p><p>The Company reported a net los
s for the six months ended June 30, 2010 of $1.5 million or $0.03 per share, compared with a net loss of $1.7 million or $0.03 per share during the comparable period of 2009.</p><p>Second Quarter Financial Results</p><p>Net sales were $5.1 million during the second quarter 2010, compared with $5.5 million during the comparable period of 2009. Gross profit was $2.5 million or 49% of net sales during the second quarter of 2010, compared with gross profit of $2.7 million or 48% of net sales during the comparable period of 2009. &#160;Operating expenses were $3.5 million during the second quarter of 2010, which included expense from foreign currency revaluation of $0.4 million. &#160;Operating expenses were $3.4 million during the same period of 2009, which included expense from foreign currency revaluation of $0.2 million. &#160;Cash and cash equivalents were $5.4 million as of June 30, 2010, compared with $5.6 million as of December 31, 2009.</p><p>The net loss for the second quarter of 2010 was $1.1 million o
r $0.02 per share, compared with a net loss of $730,000 or $0.01 per share for the second quarter of 2009.</p><p><u><b>Comment and Outlook</b></u></p><p>Craig Tuttle, president and chief executive officer of Transgenomic, said, &#34;We have positioned Transgenomic to play an important role in the rapidly growing field of personalized medicine. &#160;Although companion diagnostics are of keen importance to patients, they also are important to large pharmaceutical companies as they support success in drug development owing to better patient selection, while improved efficacy and more sophisticated technology argue for appropriate drug pricing. Our COLD-PCR technology, which we licensed from Dana Farber Cancer Institute last year and continue to develop, is well-suited to this initiative as it permits mutation detection with as much as 100 times the sensitivity of currently available processes.</p><p>&#34;Our pharmacogenomics services business is the most rapidly growing area of our business, with sales up 23% 
versus the second quarter of last year, albeit off a small base. In addition, revenues can be irregular and receipt of testing samples is dependent on the pace of patient recruitment in our pharmaceutical customers&#39; clinical trials. &#160;However, we are very pleased that the pipeline of proposals submitted to pharmaceutical companies stood at $6.0 million as of June 30, compared with $2 million as of March 31, 2010. &#160;Clearly there is a great deal of interest in the science of biomarker discovery.</p><p>&#34;During the quarter we sold our first K-RAS kit in Europe. &#160;This kit uses our SURVEYOR&#174; Nuclease technology, and we expect to complete the process of receiving a CE-IVD Mark for the kit in the third quarter. &#160;This designation will allow wider distribution to commercial laboratories. &#160;We continue to work on additional assays to add to a panel of kits that we are developing to test for resistance to cancer treatment with epidermal growth factor receptor inhibitors.</p><p>&#34;We
 met a significant milestone with the sale of our first ARISk&#8482; test run following the extensive technical development and validation process of this test. &#160;ARISk determines if there is an increased risk of autism in a newborn with an autistic older biological sibling. &#160;We plan to aggressively market the test in the coming months and expect demand for this test to be high. &#160;In addition to performing this assay in our CLIA-certified laboratory and selling the assay through our field sales organization, we are cooperating with IntegraGen, our licensing partner, to market this test.&#34;</p><p>Commenting on second quarter instrument sales, Mr. Tuttle noted, &#34;Our instrument business was impacted by lower consumable revenue, the decline in the euro relative to the U.S. dollar and product mix. &#160;However, we were pleased to sell 14 WAVE&#174; systems during the second quarter.&#34;</p><p><u><b>Conference Call</b></u></p><p>Company management will discuss second quarter 2010 financial res
ults and answer questions during a conference call today beginning at 5:00 p.m. Eastern time. To access the call via telephone, please dial 888-563-6275 (domestic) or 706-643-3137 (international) and enter conference ID number 92483964. &#160;The call also will be broadcast live over the Internet. To listen to the webcast, please log onto the Company&#39;s Investor Relations web page at http://www.transgenomic.com/events.asp?id=6 and follow the instructions. An archived webcast of the call will be available for 30 days. Investors can listen to a replay via telephone until 11:59 p.m. Eastern time on Saturday, August 14, 2010 by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and entering conference ID number 92483964. </p><p><u><b>About Transgenomic, Inc. &#160;</b></u></p><p>Transgenomic, Inc. (www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discover
y for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE&#174; Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, nearly 1,500 systems have been shipped to customers in more than 50 countries. The SURVEYOR&#174; Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared with manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomics 
Services is a CRO for pharmacogenomic, translational research and clinical trials.</p><p><u><b>Forward-Looking Statements</b></u></p><p>Certain statements in this press release constitute &#34;forward-looking statements&#34; of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management&#39;s current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic&#39;s fil
ings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.</p><div style="margin-bottom:.0001in; margin-top:.0001in"><table cellspacing="0" cellpadding="3" style="border-collapse:collapse;border:none;"><tr><td valign="bottom" colspan="8" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Transgenomic, Inc. and Subsidiary</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Summary Financial Results</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Unaudited Condensed Consolidated Statements of Operations</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">(dollars in thousands except per share data)</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; padding-right: 12pt; padding-left: 10pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Three Months Ended</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">June 30,</font></b><font style="font-family:Arial;font-size:8pt;"></font></p></td><td valign="bottom" colspan="4" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Six Months Ended</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">June 30,</font></b><font style="font-family:Arial;font-size:8pt;"></font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; border-bottom:solid black 1pt; padding-right: 12pt; padding-left: 10pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2010</font></b><font style="font-family:Arial;font-size:8pt;"> &#160;</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; border-bottom:solid black 1pt; padding-right: 12pt; padding-left: 10pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2009</font></b><font style="font-family:Arial;font-size:8pt;"> &#160;</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2010</font></b><font style="font-family:Arial;font-size:8pt;"> &#160;</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.
4pt 5.4pt;border-top:solid black 1pt; border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2009</font></b><font style="font-family:Arial;font-size:8pt;"> &#160;</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET SALES</font></b><font style="font-family:Arial;font-size:8pt;"></font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;5,095</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;5,473</font></p></td><td valign="bottom" colspan="3" style=
"padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;10,537</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;10,463</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">COST OF GOODS SOLD</font></b><font style="font-family:Arial;font-size:8pt;"></font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,608</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left
: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,822</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5,166</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,999</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 24pt;"><font style="font-family:Arial;font-size:8pt;">Gross profit </font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,487</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,651</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5,371</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: 
nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5,464</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">OPERATING EXPENSES:</font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 24pt;"><font style="font-family:Arial;font-size:8pt;">Selling, general and administrative </font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">3,033</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,732</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5,464</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; ">
<font style="font-family:Arial;font-size:8pt;">5,708</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 24pt;"><font style="font-family:Arial;font-size:8pt;">Research and development </font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">512</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">686</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1,339</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-rig
ht: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1,530</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">3,545</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">3,418</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">6,803</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">7,238</font></p></td><td style=""></td></tr><tr><td valig
n="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">LOSS FROM OPERATIONS</font></b><font style="font-family:Arial;font-size:8pt;"></font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,058)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(767)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,432)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: no
wrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,774)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">OTHER INCOME (EXPENSE):</font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 12pt; padding-left: 10pt; ">
<br /></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 24pt;"><font style="font-family:Arial;font-size:8pt;">Interest income </font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;f
ont-size:8pt;">14</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 24pt;"><font style="font-family:Arial;font-size:8pt;">Other, net</font></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">&#8212;</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(3)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">&#8212;</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt
;">(3)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">1</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">11</font></p></td><td style=""></td></tr><tr><td valign="bottom" st
yle="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">LOSS BEFORE INCOME TAXES </font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,057)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(768)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,431)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p sty
le="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(1,763)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">INCOME TAX EXPENSE (BENEFIT)</font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">89</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(38)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">38</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padd
ing-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(80)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET LOSS </font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160;(1,146)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;(730)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; pa
dding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; &#160; &#160; &#160; (1,469)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; &#160; &#160; &#160; &#160;(1,683)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">BASIC AND DILUTED LOSS PER SHARE</font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 6pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;(0.02)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 6pt
; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; (0.01)</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; (0.03)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;(0.03)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING </font></b></p></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-righ
t: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">49,206,339</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 9pt; padding-left: 10pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">49,189,672</font></p></td><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">49,198,005</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:double black 2.5pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">49,189,672</font></p></td><td style=""></td></tr><tr><td valign="bottom" colspan="6" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td></tr><tr><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td></tr></table>
<br />
<br /></div><div style="margin-bottom:.0001in; margin-top:.0001in"><table cellspacing="0" cellpadding="3" style="border-collapse:collapse;border:none;"><tr><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Transgenomic, Inc. and Subsidiary</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Summary Financial Results</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Unaudited Condensed Consolidated Statements of Cash Flows</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">(dollars in thousands)</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" colspan="2" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Six Months Ended</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">June 30</font></b><b><font style="font-family:Arial;font-size:8pt;">,</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2010</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">2009</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;(27)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 9p
t; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160; &#160; 193</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET CASH FLOWS USED IN INVESTING ACTIVITIES</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(126)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(232)</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">42</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">&#8212;</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(115)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">44</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">NET CHANGE IN CASH AND CASH EQUIVALENTS</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">(226)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">5,642</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,771</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">CASH AND CASH EQUIVALENTS AT END OF PERIOD</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:double black 2.5pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;5,416</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:double black 2.5pt; padding-right: 9pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;4,776</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:double black 2.5pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:double black 2.5pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td></tr></table>
<br />
<br /></div><div style="margin-bottom:.0001in; margin-top:.0001in"><table cellspacing="0" cellpadding="3" style="border-collapse:collapse;border:none;"><tr><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">Transgenomic, Inc. and Subsidiary</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Summary Financial Results</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">Unaudited Condensed Consolidated Balance Sheets</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">(dollars in thousands)</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">(Unaudited)</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">June 30,</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">2010</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-bottom:solid black 1pt; "><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">December 31,</font></b>
<br /><b><font style="font-family:Arial;font-size:8pt;">2009</font></b></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">ASSETS</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:solid black 1pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">CURRENT ASSETS:</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Cash and cash equivalents</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;5,416</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;5,642</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Accounts receivable (net of allowances for bad debts of $295 and $310, respectively)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: righ
t; "><font style="font-family:Arial;font-size:8pt;">3,827</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,522</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Inventories (net of allowance for obsolescence of $536 and $507, respectively)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">3,321</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">3,552</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p st
yle="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Prepaid expenses and other current assets</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">577</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">738</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 36pt;"><font style="font-family:Arial;font-size:8pt;">Total current assets</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">13,141</font></p></td><td val
ign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">14,454</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">PROPERTY AND EQUIPMENT, NET</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">843</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">967</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">OTHER ASSETS:</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt
 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Other assets (net of accumulated amortization of $537 and $525, respectively)</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">462</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">583</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; border-bottom:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$14,446</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; border-bottom:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$16,004</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="text-align: center; "><b><font style="font-family:Arial;font-size:8pt;">LIABILITIES AND STOCKHOLDERS&#39; EQUITY</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:double black 2.5pt; ">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;border-top:double black 2.5pt; ">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">CURRENT LIABILITIES:</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Accounts payable</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;889</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;1,013</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Other accrued expenses</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,607</font></p></td>
<td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">2,517</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Accrued compensation</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">793</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">573</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 36pt;"><font style="font-family:Arial;font-size:8pt;">T
otal current liabilities</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,289</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,103</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 12pt;"><font style="font-family:Arial;font-size:8pt;">Other long term liabilities</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">182</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-botto
m:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">239</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p style="margin-left: 36pt;"><font style="font-family:Arial;font-size:8pt;">Total liabilities</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,471</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">4,342</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;"><p><b><font style="font-family:Arial;font-size:8pt;">STOCKHOLDERS&#39; EQUITY</font></b></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.
4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">9,975</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-bottom:solid black 1pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">11,662</font></p></td><td style=""></td></tr><tr><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; border-bottom:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;14,446</font></p></td><td valign="bottom" style="padding: 0pt 5.4pt 5.4pt 5.4pt;white-space: nowrap; border-top:solid black 1pt; border-bottom:double black 2.5pt; padding-right: 6pt; "><p style="text-align: right; "><font style="font-family:Arial;font-size:8pt;">$ &#160;16,004</font></p></td><td style=""></td></tr><tr><td valign="bottom" colspan="3" style="padding: 0pt 5.4pt 5.4pt 5.4pt;">
<br /></td><td style=""></td></tr><tr><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td><td style="padding: 0pt 5.4pt 5.4pt 5.4pt;"></td></tr></table>
<br />
<br /></div>
<br /><br /><p>CONTACT: &#160;Craig Tuttle, President &amp; CEO of Transgenomic, Inc., +1-402-452-5400, investorrelations@transgenomic.com; or Investor Relations, Kim Sutton Golodetz, +1-212-838-3777, kgolodetz@lhai.com, or Bruce Voss, +1-310-691-7100, bvoss@lhai.com, both of Lippert/Heilshorn &amp; Associates, for Transgenomic, Inc.</p></div></div></body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
